Creating the Next Wave of Precision Biotherapeutics

At Radcliffe, Nicola L. B. Pohl is designing methods to integrate her group’s chemistry for automated sugar synthesis into state-of-the-art methods for automated peptide synthesis to facilitate the study of biomedically relevant glycoproteins and glycosylated peptides. She will be working with collaborators at the Harvard Medical School and at the Massachusetts Institute of Technology’s Department of Chemistry.